Literature DB >> 11597993

On the role of Ca(2+)- and voltage-dependent inactivation in Ca(v)1.2 sensitivity for the phenylalkylamine (-)gallopamil.

S Sokolov1, E Timin, S Hering.   

Abstract

L-type calcium channels (Ca(v)1.m) inactivate in response to elevation of intracellular Ca(2+) (Ca(2+)-dependent inactivation) and additionally by conformational changes induced by membrane depolarization (fast and slow voltage-dependent inactivation). Molecular determinants of inactivation play an essential role in channel inhibition by phenylalkylamines (PAAs). The relative impacts, however, of Ca(2+)-dependent and voltage-dependent inactivation in Ca(v)1.2 sensitivity for PAAs remain unknown. In order to analyze the role of the different inactivation processes, we expressed Ca(v)1.2 constructs composed of different beta-subunits (beta(1a)-, beta(2a)-, or beta(3)-subunit) in Xenopus oocytes and estimated their (-)gallopamil sensitivity by means of the two-microelectrode voltage clamp with either Ba(2+) or Ca(2+) as charge carrier. Ca(v)1.2 consisting of the beta(2a)-subunit displayed the slowest inactivation and the lowest apparent sensitivity for the PAA (-)gallopamil. A significantly higher apparent (-)gallopamil-sensitivity with Ca(2+) as charge carrier was observed for all 3 beta-subunit compositions. The kinetics of Ca(2+)-dependent inactivation and slow voltage-dependent inactivation were not affected by drug. The higher sensitivity of the Ca(v)1.2 channels for (-)gallopamil with Ca(2+) as charge carrier results from slower recovery (tau(rec,Ca) approximately 15 seconds versus tau(rec,Ba) approximately 3 to 5 seconds) from a PAA-induced channel conformation. We propose a model where (-)gallopamil promotes a fast voltage-dependent component in Ca(v)1.2 inactivation. The model reproduces the higher drug sensitivity in Ca(2+) as well as the lower sensitivity of slowly inactivating Ca(v)1.2 composed of the beta(2a)-subunit.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597993     DOI: 10.1161/hh2001.098983

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

1.  Two components of voltage-dependent inactivation in Ca(v)1.2 channels revealed by its gating currents.

Authors:  Gonzalo Ferreira; Eduardo Ríos; Nicolás Reyes
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

Review 2.  Molecular pharmacology of high voltage-activated calcium channels.

Authors:  Clinton J Doering; Gerald W Zamponi
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

3.  Structural model for phenylalkylamine binding to L-type calcium channels.

Authors:  Ricky C K Cheng; Denis B Tikhonov; Boris S Zhorov
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

4.  Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V)1.2) calcium channels.

Authors:  V Yarotskyy; K S Elmslie
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

5.  Impact of phosphomimetic and non-phosphorylatable mutations of phospholemman on L-type calcium channels gating in HEK 293T cells.

Authors:  Kai Guo; Yue-Peng Wang; Zhi-Wen Zhou; Yi-Bo Jiang; Wei Li; Xiao-Meng Chen; Yi-Gang Li
Journal:  J Cell Mol Med       Date:  2015-02-05       Impact factor: 5.310

Review 6.  Calcium channel gating.

Authors:  S Hering; E-M Zangerl-Plessl; S Beyl; A Hohaus; S Andranovits; E N Timin
Journal:  Pflugers Arch       Date:  2018-06-27       Impact factor: 4.458

7.  Key role of segment IS4 in Cav1.2 inactivation: link between activation and inactivation.

Authors:  Stanislav Andranovits; Stanislav Beyl; Annette Hohaus; Eva Maria Zangerl-Plessl; Eugen Timin; Steffen Hering
Journal:  Pflugers Arch       Date:  2017-08-01       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.